Combined NMR and MS-based metabonomics and real-time PCR analyses reveal dynamic metabolic changes of Ganoderma lucidum during fruiting body growing

Ganoderma lucidum (G. lucidum) is a rare medicinal fungus with various beneficial properties. One of its main components, ganoderic acids (GAs), are important triterpenoids known for their sedative and analgesic, hepatoprotective, and anti-tumor activities. Understanding the growth and development of the G. lucidum fruiting body is crucial for determining the optimal time to harvest them. In this study, we used nuclear magnetic resonance (NMR) spectroscopy to systematically characterize the metabolites of G. lucidum at seven distinct developmental stages. We also measured the contents of seven kinds of GAs using LC-MS/MS. A total of 49 metabolites were detected in G. lucidum, including amino acids, sugars, organic acids and GAs. During the transition from the bud development period (I) to the budding period (II), we observed a rapid accumulation of glucose, tyrosine, nicotinamide ribotide, inosine and GAs. After the budding period, the contents of most metabolites.
decreased until the mature period (VII). In addition, the contents of GAs showed an initial raising,
followed by a decline during the elongation period, except for GAF, which exhibited a rapid raise during the
mature stage. We also detected the expression of several genes involved in GA synthesis, finding that most genes
including 16 cytochrome P450 monooxygenase were all down-regulated during periods IV and VII compared to
period I. These findings provide valuable insights into the dynamic metabolic profiles of G. lucidum throughout
its growth stage, and it is recommended to harvest G. lucidum at period IV.